SELLAS Life Sciences Group, Inc. (SLS)
3.86
-0.18
(-4.46%)
USD |
NASDAQ |
Jan 08, 16:00
3.78
-0.08
(-2.07%)
After-Hours: 19:49
SELLAS Life Sciences Group Research and Development Expense (Annual): 19.10M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| GT Biopharma, Inc. | 5.798M |
| Amicus Therapeutics, Inc. | 109.36M |
| Geron Corp. | 103.74M |
| Vanda Pharmaceuticals, Inc. | 74.43M |
| ADMA Biologics, Inc. | 1.813M |